Molecular Partners Ag MOLN
NASDAQ MOLN
$4.18 -0.17 (-3.76%)
As of: Sep 10, 2026 · 9:51 AM EDT

Molecular Partners Ag (MOLN) Shares Outstanding (2020 - 2026)

Molecular Partners Ag's (MOLN) quarterly Shares Outstanding (Entity) came in at $40.4 million in Q4 2025, little changed year-over-year from $40.4 million in Q4 2024, and little changed quarter-over-quarter from $40.4 million in Q4 2024.

Analysis

Molecular Partners Ag (MOLN) Shares Outstanding (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Shares Outstanding (Entity) for 6 consecutive years, with $40.4 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Shares Outstanding (Entity) changed 0.03% year-over-year to $40.4 million in Q4 2025; TTM through Dec 2025 was $40.4 million, a 0.03% change from a year earlier, with the FY2025 full-year figure at $40.4 million, changed 0.03% from the prior year.
  • Shares Outstanding (Entity) was $40.4 million for Q4 2025 at Molecular Partners Ag, roughly flat from $40.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $40.4 million in Q4 2025 and troughed at $32.3 million in Q4 2021.
  • A 5-year average of $37.1 million and a median of $36.4 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) rose 11.62% in 2022 and gained 0.03% in 2025, its largest moves.
  • Over 5 years, Shares Outstanding (Entity) stood at $32.3 million in 2021, then gained by 11.62% to $36.0 million in 2022, then rose by 0.86% to $36.4 million in 2023, then grew by 11.03% to $40.4 million in 2024, then gained by 0.03% to $40.4 million in 2025.
  • The last three Shares Outstanding (Entity) figures came in at $40.4 million (Q4 2025), $40.4 million (Q4 2024), and $36.4 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 540.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.24 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 253.70 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 102.80 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 61.30 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 398.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 133.61 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 147.70 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 720.78 Mn
10 Molecular Partners Ag 156.54 Mn 156.54 Mn - 37.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.27 Mn
Mar 31, 2026 37.27 Mn
Dec 31, 2025 37.27 Mn
Sep 30, 2025 34.03 Mn
Jun 30, 2025 34.03 Mn
Mar 31, 2025 34.03 Mn
Dec 31, 2024 34.03 Mn
Sep 30, 2024 32.77 Mn
Jun 30, 2024 32.77 Mn
Mar 31, 2024 32.77 Mn
Dec 31, 2023 32.77 Mn
Sep 30, 2023 32.47 Mn
Jun 30, 2023 32.47 Mn
Mar 31, 2023 32.47 Mn
Dec 31, 2022 32.47 Mn
Sep 30, 2022 31.01 Mn
Jun 30, 2022 31.01 Mn
Mar 31, 2022 31.01 Mn
Dec 31, 2021 31.01 Mn
Sep 30, 2021 25.00 Mn